Suppr超能文献

线粒体ATP依赖性钾通道:心脏保护的新型效应器?

Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?

作者信息

Liu Y, Sato T, O'Rourke B, Marban E

机构信息

Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

Circulation. 1998 Jun 23;97(24):2463-9. doi: 10.1161/01.cir.97.24.2463.

Abstract

BACKGROUND

Brief interruptions of coronary blood flow paradoxically protect the heart from subsequent prolonged ischemia. The basis of such endogenous cardioprotection, known as "ischemic preconditioning," remains uncertain. Pharmacological evidence has implicated ATP-dependent potassium (KATP) channels in the mechanism of preconditioning; however, the effects of sarcolemmal KATP channels on excitability cannot account for the protection.

METHODS AND RESULTS

We simultaneously measured flavoprotein fluorescence, an index of mitochondrial redox state, and sarcolemmal KATP currents in intact rabbit ventricular myocytes. Our results show that diazoxide, a KATP channel opener, selectively activates mitochondrial KATP channels. Diazoxide induced reversible oxidation of flavoproteins with an EC50 of 27 micromol/L but did not activate sarcolemmal KATP channels. The subcellular site of diazoxide action is further localized to mitochondria by confocal imaging of fluorescence arising from flavoproteins and tetramethylrhodamine ethyl ester. In a cellular model of simulated ischemia, inclusion of diazoxide decreased the rate of cell death to about half of that in controls. Both the redox changes and protection are inhibited by the KATP channel blocker 5-hydroxydecanoic acid.

CONCLUSIONS

Our results demonstrate that diazoxide targets mitochondrial but not sarcolemmal KATP channels and imply that mitochondrial KATP channels may mediate the protection from KATP channel openers.

摘要

背景

冠状动脉血流的短暂中断反而能保护心脏免受随后的长时间缺血损伤。这种被称为“缺血预处理”的内源性心脏保护作用的机制尚不清楚。药理学证据表明,ATP依赖性钾(KATP)通道参与了预处理机制;然而,肌膜KATP通道对兴奋性的影响并不能解释这种保护作用。

方法与结果

我们同时测量了完整兔心室肌细胞中的黄素蛋白荧光(线粒体氧化还原状态的指标)和肌膜KATP电流。我们的结果表明,KATP通道开放剂二氮嗪选择性地激活线粒体KATP通道。二氮嗪诱导黄素蛋白可逆性氧化,其半数有效浓度(EC50)为27 μmol/L,但不激活肌膜KATP通道。通过黄素蛋白和四甲基罗丹明乙酯产生的荧光共聚焦成像,进一步将二氮嗪作用的亚细胞位点定位到线粒体。在模拟缺血的细胞模型中,加入二氮嗪可使细胞死亡率降至对照组的约一半。KATP通道阻滞剂5-羟基癸酸可抑制氧化还原变化和保护作用。

结论

我们的结果表明,二氮嗪作用于线粒体而非肌膜KATP通道,这意味着线粒体KATP通道可能介导了KATP通道开放剂的保护作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验